Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Black pepper leaf extract contains compounds that can block testosterone effects and promote hair growth.

Taking finasteride pills and using minoxidil lotion together can help grow hair.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Some plant-based products might treat hair loss with fewer side effects than current medications.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.